# Shaping the Future of Biotech: Join the PT Bifarma Adiluhung Manufacture Development Program
PT Bifarma Adiluhung, operating as a strategic subsidiary of PT Kalbe Farma Tbk, stands at the forefront of the biotechnology sector. Since its inception in 1966, the Kalbe Group has evolved into the largest pharmaceutical enterprise in Southeast Asia. Recognized consistently as one of Fortune Indonesia’s "Most Admired Companies," Kalbe transcends traditional manufacturing by acting as a comprehensive provider of health solutions, ranging from essential pharmaceuticals and nutritional supplements to advanced medical devices and primary care services.
## A Legacy of Excellence and Innovation
Kalbe Group’s operational scale is a testament to its commitment to global standards. With a robust infrastructure comprising over 20 subsidiaries and 10 world-class production facilities, the organization is powered by a dedicated workforce of 17,000 professionals and 6,000 marketing specialists. These experts operate across 68 branches throughout Indonesia and the broader ASEAN region, ensuring that high-quality health solutions remain accessible to millions.
Corporate Governance and Accountability
The organization operates under a stringent framework of Good Corporate Governance (GCG). The Board of Directors maintains full accountability to the General Meeting of Shareholders (GMS), ensuring transparent management practices. Performance evaluations for the directors are conducted annually by the Board of Commissioners, with results presented to the GMS to uphold the highest standards of professional integrity and strategic alignment.
## Launch Your Career: Manufacture Development Program (MDP)